Delta 10 Flower
Delta-10 flower is an infused hemp product designed for those seeking an energizing, uplifting experience.Â
Often compared to classic sativa strains, delta-10 is known for its creative and cerebral effects â perfect for fueling productive flow states or stimulating creative expression.
Looking to explore other, fully legal, cannabis options?Â
Check out our delta-8 flower, delta-9 flower, or THCA flower pages to learn more.
-
Power Up: How to Use Delta-10 Flower âĄ
Delta-10 THC flower is infused hemp designed for smoking, vaping, or baking â offering a versatile way to explore this rare cannabinoid.
- đĽ Smoke It â Roll it into a joint, pack it in a pipe, or load a pre-roll for easy use.
- đŹ Vape It â Use a dry herb vaporizer to preserve terpenes and enjoy a smoother inhale.
- đŞ Bake It â Decarb and infuse into butter or oil to create edibles with precise dosing.
For more infused flower options, check out THCA Flower or Delta-8 Flower.
THC Variants: Finding the Right Fit đż
Cannabis flower contains various cannabinoids, each offering unique effects:
- Delta-8 THC Flower â Calming and gentle, ideal for relaxation and stress relief.
- Delta-9 THC Flower â Potent and euphoric, delivering bold effects for experienced users.
- Delta-10 THC Flower â Uplifting and energizing, perfect for daytime focus and creativity.
- THCA Flower â Non-psychoactive in its raw form but converts to potent delta-9 THC when heated, delivering powerful effects.
Why Choose Area 52?
At Area 52, we donât just make Delta-10 flower â we craft an experience. Our commitment to quality, transparency, and innovation sets us apart from the rest.Â
- Top-Tier Infusion Process â We start with premium, organically-grown hemp flower and infuse it with high-potency THC diamonds.
- Lab-Tested for Purity â Every batch of our hemp flower is third-party tested for potency, residual solvents, pesticides, & contaminants.
- No Cutting Agents or Synthetic Additives â We keep it clean and natural, avoiding harsh chemicals or artificial enhancers that could compromise quality.
- Strain-Specific Options â Whether you’re looking for fruity, citrus-forward sativa effects or earthy, piney hybrid balance, we source only high-terpene, aromatic strains that amplify our flower’s unique properties.
- Fast & Secure Shipping â We deliver nationwide with discreet, secure packaging so your order arrives fresh and ready to enjoy.
Our Commitment to Quality đŹ
We believe in full transparency when it comes to our Delta-10 products. Every batch undergoes third-party lab testing to verify:
- Potency Levels â Ensuring accurate THC content.
- Residual Solvents â Free from harmful extraction chemicals.
- Pesticides & Contaminants â Screening for purity and safety.
- Terpene Profiles â Confirming strain-specific flavor and effects.
Lab reports are available for every product so you can verify exactly whatâs in your Delta-10 flower before you buy.
FAQs: Delta-10 Flower
What Is Delta-10 Flower?
Delta-10 flower is made using premium hemp flower infused with delta-10 THC diamond extracts, enhancing the natural cannabinoids and terpenes in the plant. This creates a smooth, flavorful product known for its energizing and uplifting effects, perfect for those seeking a balanced yet stimulating experience.
How Is Delta-10 Flower Used?
You can enjoy delta-10 flower in several ways:
- Smoking: Roll it into a joint or pack it into a pipe for fast-acting effects.
- Vaping: Use a dry herb vaporizer to maximize flavor and preserve terpenes.
- Baking: Decarboxylate the flower to infuse it into butter or oil for edibles.
- Each method offers a unique experience, so you can choose the one that best fits your needs.
What Are The Effects Of Delta-10 Flower?
Delta-10 THC is uplifting and mildly psychoactive, making it ideal for daytime activities, creative pursuits, or socializing. Its effects are more stimulating than delta-8 but less intense than delta-9, providing a middle ground that many users find enjoyable and functional.
Is Delta-10 Flower Legal?
Yes, delta-10 flower is federally legal under the 2018 Farm Bill, as long as itâs hemp-derived and contains less than 0.3% delta-9 THC by weight. Some states have stricter regulations, so check your local laws before purchasing.
How Does Delta-10 Compare to Delta-9 or Delta-8?
Delta-10 THC offers a distinct experience compared to its counterparts (more stimulating, in general).
Delta-8 THC is best known for its relaxing and calming effects, making it ideal for unwinding. Delta-9 THC delivers stronger psychoactive effects, which can be overwhelming for some users.Â
In contrast, delta-10 THC provides a clear-headed, uplifting effect that enhances focus and creativity, making it a great option for daytime use without the intensity of delta-9.
How Should I Store My Delta-10 Flower?
Always store delta-10 flower in an airtight container, away from light, heat, and air, to maintain its potency and flavor. A glass jar with a sealed lid in a cool, dark place is ideal for preserving freshness.
Can Delta-10 Flower Be Blended with Other Cannabinoids?
Yes! Our delta-10 flower can be combined with delta-8, delta-9, THCA, or CBD flower as well as various concentrates (such as THC diamonds, CBD diamonds, dabs, live resins, and more) for more balanced or intense effects.
Will Delta-10 Flower Show Up on a Drug Test?
Yes. Delta-10 THC metabolizes similarly to delta-9 THC, meaning it can trigger a positive result on a standard drug test. If youâre subject to testing, we recommend avoiding delta-10, or any other type of THC flower.
How Potent Is Delta-10 Compared to Delta-8 & Delta-9?
Delta-10 is milder than delta-9 but slightly stronger than delta-8 in terms of psychoactive effects. While delta-9 provides a more intense, traditional THC high,dDelta-10 offers a lighter, more functional buzz thatâs great for daytime use.
How Long Do the Effects of Delta-10 Flower Last?
The effects of delta-10 flower typically last between 2 to 4 hours, depending on your metabolism, dosage, and tolerance. Delta-10 flower shares a similar onset and duration of effects as both delta-9 and delta-8 flower.
References
[1] Chattopadhyay, M., Chanda, A., & Bhattacharya, A. (2024). Therapeutic application of cannabis and its derivatives. Elsevier. https://doi.org/10.1016/b978-0-443-15489-8.00003-7 [2] Holdman, R., Vigil, D., Robinson, K., Shah, P., & Contreras, A. E. (2022). Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications. Mary Ann Liebert Inc. https://doi.org/10.1089/can.2020.0154 [3] Davenport, S. (2020). Public Health and Safety Consequences of Liberalizing Drug Laws: Insights from Cannabis Legalization. RAND Corporation. https://doi.org/10.7249/rgda508-1 [4] Islam, F. A. (2017). Cannabis Exacerbation of Bipolar Disorder. MedCrave Group, LLC. https://doi.org/10.15406/mojamt.2017.03.00026 [5] Copersino, M. L., Boyd, S. J., Tashkin, D. P., Huestis, M. A., Heishman, S. J., Dermand, J. C., Simmons, M. S., & Gorelick, D. A. (2006). Cannabis Withdrawal Among NonâTreatmentâSeeking Adult Cannabis Users*. Wiley. https://doi.org/10.1080/10550490500418997 [6] Salz, T., Meza, A. M., Chino, F., Mao, J. J. J., Raghunathan, N. J., Jinna, S., Brens, J., Hernandez, M., & Korenstein, D. (2022). Sociodemographic predictors of cannabis use among patients with cancer residing in states with legalized cannabis.. American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2022.40.28_suppl.299 [7] IVERSEN, L. (2004). Cannabis and the law â high time for reform?. Cambridge University Press (CUP). https://doi.org/10.1017/s1062798704000444 [8] Drugs, N. O. o., & Crime (2019). Cannabis et Hallucinogènes. United Nations. https://doi.org/10.18356/9789210041751c005 [9] da Rocha, A. G., Almeida, D. Q., & Almeida, M. (2021). Recreational cannabis consumption: a public health perspective. Oxford University Press (OUP). https://doi.org/10.1093/eurpub/ckab165.011 [10] Staples, A. J. (2024). Beer drinker perceptions of cannabis-infused beverages. Emerald. https://doi.org/10.1108/bfj-02-2024-0209 [11] Walter, D., Ballke, E., Schmidt, S., Lodziewski, S., Bollmann, T., Lorenz, G., & Ewert, R. (2005). Hämoptysen als Manifestation nach Cannabis-Inhalation. Georg Thieme Verlag KG. https://doi.org/10.1055/s-2005-864370 [12] Steinhart, B., Brooks-Russell, A., Kosnett, M. J., Subramanian, P. S., & Wrobel, J. (2023). A Video Segmentation Pipeline for Assessing changes in Pupil Response to Light After Cannabis Consumption. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.03.17.533144 [13] BenâZeev, B. (2021). Epilepsy and cannabis: facing reality. Wiley. https://doi.org/10.1111/dmcn.15081 [14] Lucas-Parrales, E. N., BazĂĄn-Mosquera, A. Ă., & MerchĂĄn-CĂłrdova, O. J. (2023). Conductas adictivas: situaciĂłn actual de cannabis y consecuencias en adolescentes.. MQRinvestigar. https://doi.org/10.56048/mqr20225.7.3.2023.3690-3703 [15] Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020). Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. Springer Science and Business Media LLC. https://doi.org/10.1186/s12888-019-2409-8 [16] Jin, D., Dai, K., Xie, Z., & Chen, J. (2020). Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes. Springer Science and Business Media LLC. https://doi.org/10.1038/s41598-020-60172-6 [17] Hutflesz, C., & Parihar, V. (2019). Medical Cannabis Induced Acute Pancreatitis and Hyperemesis Syndrome in a Patient with Complex Regional Pain Syndrome. Informa UK Limited. https://doi.org/10.1080/24740527.2019.1592390 [18] Bosse, J. (2020). Before the High Court: the legal systematics of Cannabis. Informa UK Limited. https://doi.org/10.1080/10383441.2020.1804671 [19] Hirst, R. A., Lambert, D. G., & Notcutt, W. G. (1998). Pharmacology and potential therapeutic uses of cannabis. Elsevier BV. https://doi.org/10.1093/bja/81.1.77 [20] Brodbeck, J., Matter, M., & Moggi, F. (2006). Association Between Cannabis Use and Sexual Risk Behavior Among Young Heterosexual Adults. Springer Science and Business Media LLC. https://doi.org/10.1007/s10461-006-9103-9 [21] Mata, H. P. U. I. P., Tarragona, & Chorto, S. P. (2020). Diferencias de gĂŠnero en la dependencia de cannabis y las razones de consumo. Impacto en el trastorno bipolar y los primeros episodios.. SEPD. https://doi.org/10.17579/sepd2020o001 [22] Van Dam, N. T., Earleywine, M., & DiGiacomo, G. (2008). Polydrug use, cannabis, and psychosisâlike symptoms. Wiley. https://doi.org/10.1002/hup.950 [23] Kumar, R. N., Chambers, W. A., & Pertwee, R. G. (2001). Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Wiley. https://doi.org/10.1046/j.1365-2044.2001.02269.x [24] Saeed, S. R., Timms, M. S., & Woolford, T. J. (1993). Cannabis in the ear â the legal aspects. Cambridge University Press (CUP). https://doi.org/10.1017/s0022215100125034 [25] Jakarasi, M. (2025). Smoked or Bewitched? The Relationship Between Cannabis Use and Mental Illness Among the Shona Persons in Zimbabwe. Springer Science and Business Media LLC. https://doi.org/10.1007/s11013-025-09898-4 [26] Mumm, L. E., Huckins, G., Lueck, L., Piskorowski, K., & Sladky, K. K. (2022). Cannabis toxicity in a pet rabbit (Oryctolagus cuniculus). Elsevier BV. https://doi.org/10.1053/j.jepm.2022.06.004 [27] Bucchino, L., Monzani, A., Fracon, S., Genoni, G., Cena, T., & Bellone, S. (2019). Cannabis-Related Diffuse Alveolar Hemorrhage in a 16-Year-Old Patient: A Case Report. Frontiers Media SA. https://doi.org/10.3389/fped.2019.00468 [28] Saade, A., Carty, M., Shahisavandi, N., Rajaraman, K., LeBlanc, M., Wrigley, S., & Rajaraman, M. (2024). 160 Cannabis Use in Cancer Patients Six Years Post-Legalization in Canada. Elsevier BV. https://doi.org/10.1016/s0167-8140(24)03651-x [29] Chatwin, C. (2011). Weed, Need and Greed: A Study of Domestic Cannabis Cultivation. By Gary Potter (London: Free Association Books, 2010, 276pp. 17.95 pb). Oxford University Press (OUP). https://doi.org/10.1093/bjc/azr046 [30] Chen-Sankey, J., La Cparia, K., Glasser, A., Padon, A. A., Moran, M. B., Wagoner, K. G., Jackson, K. M., & Berg, C. J. (2024). Associations between e-cigarette marketing exposure and vaping nicotine and cannabis among U.S. adults, 2021. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.02.03.24302079 [31] Ghannem, M., Belhadj, I., Tritar, A., Moukala, T., Amri, N., Noury, A., & Zaghdoudi, M. (2013). Cannabis et syndromes coronariens aigus avec sus-dĂŠcalage de ST. Elsevier BV. https://doi.org/10.1016/j.ancard.2013.09.002 [32] Brown, T., Schmitt, R., Milavetz, G., Gaffney, G., Brooks-Russell, A., & Berka, C. (2021). Cannabis use and reported effects on driving among adults in Iowa. Informa UK Limited. https://doi.org/10.1080/15389588.2021.1983382 [33] VenderovĂĄ, K., RĹŻĹžiÄka, E., VoĹĂĹĄek, V., & ViĹĄĹovskĂ˝, P. (2004). Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms. Wiley. https://doi.org/10.1002/mds.20111 [34] Chan, K. (2014). Validating a gas chromatography-mass spectrometric method and sample classification procedure for cannabis profiling using cannabinoids from case samples. Informa UK Limited. https://doi.org/10.1080/00450618.2014.882985 [35] Akbari, M., Bahadori, M. H., Mohammadkhani, S., Kolubinski, D. C., NikÄeviÄ, A. V., & Spada, M. M. (2021). A discriminant analysis model of psychosocial predictors of problematic Internet use and cannabis use disorder in university students. Elsevier BV. https://doi.org/10.1016/j.abrep.2021.100354 [36] Devi, V., & Khanam, S. (2019). Comparative study of different extraction processes for hemp (Cannabis sativa) seed oil considering physical, chemical and industrial-scale economic aspects. Elsevier BV. https://doi.org/10.1016/j.jclepro.2018.10.036 [37] Hayatbakhsh, M. R., McGee, T. R., Bor, W., Najman, J. M., Jamrozik, K., & Mamun, A. A. (2008). Child and adolescent externalizing behavior and cannabis use disorders in early adulthood: An Australian prospective birth cohort study. Elsevier BV. https://doi.org/10.1016/j.addbeh.2007.10.004 [38] NILSSON, J. L. G., NILSSON, I. M., AGURELL, S., AKERMARK, B. +., & LAGERLUND, I. (1971). ChemInform Abstract: METABOLISMUS VON CANNABIS 11. MITT. SYNTH. VON DELTA(7)âTETRAHYDROCANNABINOL UND 7âHYDROXYâTETRAHYDROCANNABINOL. Wiley. https://doi.org/10.1002/chin.197133295 [39] Wallace, A. L., Wade, N. E., Hatcher, K. F., & Lisdahl, K. M. (2018). Effects of Cannabis Use and Subclinical ADHD Symptomology on Attention Based Tasks in Adolescents and Young Adults. Oxford University Press (OUP). https://doi.org/10.1093/arclin/acy080 [40] Felicity, W., Samantha, B., Lisa-marie, G., Rodney, C., Juanita, T., Patricia, M., Stuart, J., Ben, L., Hannah, C., & Nadia, S. (2013). An investigation of Mismatch Negativity in current and ex- cannabis users using a feature controlled method. Frontiers Media SA. https://doi.org/10.3389/conf.fnhum.2013.213.00021 [41] Norberg, M. M., Olivier, J., Schmidt, N. B., & Zvolensky, M. J. (2013). Cannabis Use among TreatmentâSeeking Smokers: Motives and the Moderating Effects of Anxiety Sensitivity. Wiley. https://doi.org/10.1111/j.1521-0391.2013.12054.x [42] Espinoza, L. M., Naranjo, N. A., & Cardenas, M. M. (2023). Extraction, separation, and purification of cannabinoids from the Cannabis sativa L. plant using dry ice and solvents such as hexane and ethanol to determine the most efficient method. IEEE. https://doi.org/10.1109/etcm58927.2023.10308993 [43] Gawrysiak, M., Loomis, D., Ehmann, S., Wayne, S., & Armao, M. (2024). Environmental Suppression Mediates the Relationship Between Posttraumatic Stress and Cannabis Use Among Trauma-Exposed College Students. Alcohol Research Documentation, Inc.. https://doi.org/10.15288/jsad.23-00344 [44] Myhre, M. Ă., Rognli, E. B., Walby, F. A., Bramness, J. G., & Mehlum, L. (2024). The annual trend of suicide rates from 2010 to 2021 in patients with cannabis use disorder â a national registry study. Springer Science and Business Media LLC. https://doi.org/10.1007/s00127-024-02781-4 [45] Choo, E. K., Trent, S. A., Nishijima, D. K., Eichelberger, A., Kazmierczak, S., Ye, Y., Brasel, K. J., Audett, A., & Cherpitel, C. J. (2024). Risk of motor vehicle collision associated with cannabis and alcohol use among patients presenting for emergency care. Elsevier BV. https://doi.org/10.1016/j.aap.2024.107459 [46] Dyar, C., Feinstein, B. A., Crosby, S., Newcomb, M. E., & Whitton, S. W. (2021). Social Context of Cannabis Use: Associations With Problematic Use, Motives for Use, and Protective Behavioral Strategies Among Sexual and Gender Minorities Assigned Female at Birth. Springer Publishing Company. https://doi.org/10.1891/lgbtq-2020-0075 [47] Bo, A., Martinez, A., Zhou, J., Bauer, D., Joseph, P. L., & Goings, T. C. (2025). Age patterns and predictors of cannabis initiation among biracial and monoracial U.S. youth. Informa UK Limited. https://doi.org/10.1080/00952990.2025.2461520 [48] Bruijnzeel, A. W., Knight, P., Panunzio, S., Xue, S., Bruner, M. M., Wall, S. C., Pompilus, M., Febo, M., & Setlow, B. (2019). Effects in rats of adolescent exposure to cannabis smoke or THC on emotional behavior and cognitive function in adulthood. Springer Science and Business Media LLC. https://doi.org/10.1007/s00213-019-05255-7 [49] Bhattacharyya, S., Iyegbe, C., Atakan, Z., Martin-Santos, R., Crippa, J. A., Xu, X., Williams, S., Brammer, M., Rubia, K., Prata, D., Collier, D. A., & McGuire, P. K. (2014). Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control. Cambridge University Press (CUP). https://doi.org/10.1017/s0033291714000920 [50] Huáťłnh, C., BeaulieuâThibodeau, A., Fallu, J., Bergeron, J., Jacques, A., & Brochu, S. (2022). Typologies of Canadian young adults who drive after cannabis use: A twoâstep cluster analysis. Wiley. https://doi.org/10.1002/bsl.2575 
Add to cart
100% Money Back GuaranteeSorry!
This product is not available in the selected location.
